annual CFI:
-$1.29M+$4.80M(+78.84%)Summary
- As of today (July 1, 2025), OCUL annual cash flow from investing activities is -$1.29 million, with the most recent change of +$4.80 million (+78.84%) on December 31, 2024.
- During the last 3 years, OCUL annual CFI has fallen by -$94.00 thousand (-7.87%).
- OCUL annual CFI is now -103.47% below its all-time high of $37.07 million, reached on December 31, 2016.
Performance
OCUL Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$1.93M-$1.73M(-856.93%)Summary
- As of today (July 1, 2025), OCUL quarterly cash flow from investing activities is -$1.93 million, with the most recent change of -$1.73 million (-856.93%) on March 31, 2025.
- Over the past year, OCUL quarterly CFI has dropped by -$1.68 million (-658.04%).
- OCUL quarterly CFI is now -107.77% below its all-time high of $24.87 million, reached on March 31, 2016.
Performance
OCUL quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$2.97M-$1.68M(-130.28%)Summary
- As of today (July 1, 2025), OCUL TTM cash flow from investing activities is -$2.97 million, with the most recent change of -$1.68 million (-130.28%) on March 31, 2025.
- Over the past year, OCUL TTM CFI has dropped by -$3000.00 (-0.10%).
- OCUL TTM CFI is now -106.47% below its all-time high of $45.86 million, reached on September 30, 2016.
Performance
OCUL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
OCUL Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +78.8% | -658.0% | -0.1% |
| 3 y3 years | -7.9% | -600.4% | -126.1% |
| 5 y5 years | +42.5% | -676.3% | -112.8% |
OCUL Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.9% | +78.8% | -2071.9% | +42.8% | -130.3% | +64.3% |
| 5 y | 5-year | -53.1% | +78.8% | -2071.9% | +42.8% | -295.5% | +64.3% |
| alltime | all time | -103.5% | +96.7% | -107.8% | +94.9% | -106.5% | +96.0% |
OCUL Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$1.93M(+856.9%) | -$2.97M(+130.3%) |
| Dec 2024 | -$1.29M(-78.8%) | -$202.00K(+127.0%) | -$1.29M(-16.6%) |
| Sep 2024 | - | -$89.00K(-88.0%) | -$1.54M(-9.9%) |
| Jun 2024 | - | -$742.00K(+191.0%) | -$1.72M(-42.1%) |
| Mar 2024 | - | -$255.00K(-44.4%) | -$2.96M(-51.3%) |
| Dec 2023 | -$6.09M(+63.8%) | -$459.00K(+77.2%) | -$6.09M(-21.7%) |
| Sep 2023 | - | -$259.00K(-87.0%) | -$7.78M(-6.4%) |
| Jun 2023 | - | -$1.99M(-41.1%) | -$8.31M(+21.9%) |
| Mar 2023 | - | -$3.38M(+57.2%) | -$6.82M(+83.5%) |
| Dec 2022 | -$3.71M(+211.1%) | -$2.15M(+170.8%) | -$3.71M(+69.2%) |
| Sep 2022 | - | -$794.00K(+60.4%) | -$2.20M(+30.9%) |
| Jun 2022 | - | -$495.00K(+79.3%) | -$1.68M(+27.9%) |
| Mar 2022 | - | -$276.00K(-56.3%) | -$1.31M(+9.9%) |
| Dec 2021 | -$1.19M(+42.0%) | -$631.00K(+128.6%) | -$1.19M(+46.3%) |
| Sep 2021 | - | -$276.00K(+114.0%) | -$816.00K(+8.2%) |
| Jun 2021 | - | -$129.00K(-18.4%) | -$754.00K(+0.5%) |
| Mar 2021 | - | -$158.00K(-37.5%) | -$750.00K(-10.8%) |
| Dec 2020 | -$841.00K(-62.4%) | -$253.00K(+18.2%) | -$841.00K(-29.3%) |
| Sep 2020 | - | -$214.00K(+71.2%) | -$1.19M(-14.7%) |
| Jun 2020 | - | -$125.00K(-49.8%) | -$1.39M(-20.9%) |
| Mar 2020 | - | -$249.00K(-58.6%) | -$1.76M(-21.3%) |
| Dec 2019 | -$2.24M(+18.5%) | -$601.00K(+43.4%) | -$2.24M(+5.8%) |
| Sep 2019 | - | -$419.00K(-15.0%) | -$2.12M(-2.5%) |
| Jun 2019 | - | -$493.00K(-32.0%) | -$2.17M(-2.8%) |
| Mar 2019 | - | -$725.00K(+51.4%) | -$2.23M(+18.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$1.89M(-107.0%) | -$479.00K(+1.3%) | -$1.89M(-4.3%) |
| Sep 2018 | - | -$473.00K(-14.9%) | -$1.97M(+271.1%) |
| Jun 2018 | - | -$556.00K(+45.9%) | -$532.00K(-102.8%) |
| Mar 2018 | - | -$381.00K(-32.4%) | $18.73M(-30.5%) |
| Dec 2017 | $26.95M(-27.3%) | -$564.00K(-158.2%) | $26.95M(+62.0%) |
| Sep 2017 | - | $969.00K(-94.8%) | $16.64M(-38.3%) |
| Jun 2017 | - | $18.70M(+138.4%) | $26.99M(+34.7%) |
| Mar 2017 | - | $7.85M(-172.1%) | $20.04M(-45.9%) |
| Dec 2016 | $37.07M(-196.1%) | -$10.88M(-196.1%) | $37.07M(-19.2%) |
| Sep 2016 | - | $11.32M(-3.7%) | $45.86M(+559.2%) |
| Jun 2016 | - | $11.76M(-52.7%) | $6.96M(+67.3%) |
| Mar 2016 | - | $24.87M(-1292.4%) | $4.16M(-110.8%) |
| Dec 2015 | -$38.57M(-0.0%) | -$2.09M(-92.4%) | -$38.57M(-48.1%) |
| Sep 2015 | - | -$27.59M(-408.0%) | -$74.25M(+58.2%) |
| Jun 2015 | - | $8.96M(-150.2%) | -$46.94M(-16.4%) |
| Mar 2015 | - | -$17.85M(-52.7%) | -$56.14M(+45.5%) |
| Dec 2014 | -$38.59M(+9870.5%) | -$37.77M(>+9900.0%) | -$38.59M(+3664.5%) |
| Sep 2014 | - | -$274.00K(+10.5%) | -$1.02M(+19.2%) |
| Jun 2014 | - | -$248.00K(-16.5%) | -$860.00K(+29.7%) |
| Mar 2014 | - | -$297.00K(+44.2%) | -$663.00K(+71.3%) |
| Dec 2013 | -$387.00K(-110.1%) | -$206.00K(+89.0%) | -$387.00K(+113.8%) |
| Sep 2013 | - | -$109.00K(+113.7%) | -$181.00K(+151.4%) |
| Jun 2013 | - | -$51.00K(+142.9%) | -$72.00K(+242.9%) |
| Mar 2013 | - | -$21.00K | -$21.00K |
| Dec 2012 | $3.81M | - | - |
FAQ
- What is Ocular Therapeutix annual cash flow from investing activities?
- What is the all time high annual CFI for Ocular Therapeutix?
- What is Ocular Therapeutix annual CFI year-on-year change?
- What is Ocular Therapeutix quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly CFI year-on-year change?
- What is Ocular Therapeutix TTM cash flow from investing activities?
- What is the all time high TTM CFI for Ocular Therapeutix?
- What is Ocular Therapeutix TTM CFI year-on-year change?
What is Ocular Therapeutix annual cash flow from investing activities?
The current annual CFI of OCUL is -$1.29M
What is the all time high annual CFI for Ocular Therapeutix?
Ocular Therapeutix all-time high annual cash flow from investing activities is $37.07M
What is Ocular Therapeutix annual CFI year-on-year change?
Over the past year, OCUL annual cash flow from investing activities has changed by +$4.80M (+78.84%)
What is Ocular Therapeutix quarterly cash flow from investing activities?
The current quarterly CFI of OCUL is -$1.93M
What is the all time high quarterly CFI for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly cash flow from investing activities is $24.87M
What is Ocular Therapeutix quarterly CFI year-on-year change?
Over the past year, OCUL quarterly cash flow from investing activities has changed by -$1.68M (-658.04%)
What is Ocular Therapeutix TTM cash flow from investing activities?
The current TTM CFI of OCUL is -$2.97M
What is the all time high TTM CFI for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM cash flow from investing activities is $45.86M
What is Ocular Therapeutix TTM CFI year-on-year change?
Over the past year, OCUL TTM cash flow from investing activities has changed by -$3000.00 (-0.10%)